Mary Victoria Solanto

Affiliations: 
Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
hyperactive children
Google:
"Mary Solanto"
Mean distance: 16.05 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Faraone SV, Banaschewski T, Coghill D, et al. (2021) The World Federation of ADHD International Consensus Statement: 208 Evidence-based Conclusions about the Disorder. Neuroscience and Biobehavioral Reviews
Scheres A, Solanto MV. (2021) Do ADHD Symptoms, Executive Function, and Study Strategies Predict Temporal Reward Discounting in College Students with Varying Levels of ADHD Symptoms? A Pilot Study. Brain Sciences. 11
Solanto MV. (2018) The Prevalence of "Late-Onset" ADHD in a Clinically Referred Adult Sample. Journal of Attention Disorders. 1087054718765672
Solanto MV, Surman CB, Alvir JMJ. (2018) The efficacy of cognitive-behavioral therapy for older adults with ADHD: a randomized controlled trial. Attention Deficit and Hyperactivity Disorders
Solanto MV. (2017) Child vs Adult Onset of Attention-Deficit/Hyperactivity Disorder. Jama Psychiatry
Zametkin AJ, Solanto MV. (2017) A Review of ADHD Nation Adhd Report, The. 25: 6-10
Solanto MV. (2017) 27.2 Identification and Treatment of Attention-Deficit/Hyperactivity Disorder in Young Adults Attending College Journal of the American Academy of Child and Adolescent Psychiatry. 56
Leikauf JE, Solanto MV. (2016) Sluggish Cognitive Tempo, Internalizing Symptoms, and Executive Function in Adults With ADHD. Journal of Attention Disorders. 1087054716682337
Solanto MV. (2016) Commentary: Development of a new, much-needed, cognitive-behavioral intervention for adolescents with ADHD - a reflection on Sprich et al. (2016). Journal of Child Psychology and Psychiatry, and Allied Disciplines. 57: 1227-1228
Adler LA, Solanto M, Escobar R, et al. (2016) Executive Functioning Outcomes Over 6 Months of Atomoxetine for Adults With ADHD: Relationship to Maintenance of Response and Relapse Over the Subsequent 6 Months After Treatment. Journal of Attention Disorders
See more...